PaclitaxelInduction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsCisplatinCombined Modality TherapyRemission InductionChemotherapy, AdjuvantAntineoplastic Agents, PhytogenicTreatment OutcomeDisease-Free SurvivalCarboplatinAntineoplastic AgentsDoxorubicinCyclophosphamideSurvival AnalysisDrug Administration ScheduleTaxoidsEtoposideLung NeoplasmsSurvival RateNeoplasm StagingHead and Neck NeoplasmsNeoadjuvant TherapyCytarabineCarcinoma, Squamous CellLeukemia, Myeloid, AcuteFluorouracilDaunorubicinIfosfamideCarcinoma, Non-Small-Cell LungPrognosisBreast NeoplasmsVincristineVinblastineDeoxycytidineRadiotherapy, AdjuvantEnzyme InductionNeutropeniaDrug Resistance, NeoplasmChemoradiotherapyMethotrexatePrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm Recurrence, LocalDose-Response Relationship, DrugIdarubicinLaryngectomyHypopharyngeal NeoplasmsRadiotherapyRadiotherapy DosageSalvage TherapyBleomycinTime FactorsBridged CompoundsInfusions, IntravenousLeukemia, MyeloidTransplantation, AutologousGranulocyte Colony-Stimulating FactorKaplan-Meier EstimateFollow-Up StudiesOvarian NeoplasmsNasopharyngeal NeoplasmsAntimetabolites, AntineoplasticMelphalanTesticular NeoplasmsProspective StudiesLaryngeal NeoplasmsMitoxantroneOrganoplatinum CompoundsDose FractionationLeukopeniaAsparaginaseAnthracyclinesAdenocarcinomaCell Line, TumorMucositisP-GlycoproteinOrgan Sparing TreatmentsFeasibility StudiesHematopoietic Stem Cell TransplantationLevoleucovorinVindesineCranial IrradiationMesnaNeoplasmsNeoplasms, Germ Cell and EmbryonalThiotepaGlossectomyRadiotherapy, High-EnergyAntibiotics, AntineoplasticThrombocytopeniaRecurrenceAntibodies, Monoclonal, HumanizedGerminomaApoptosisConsolidation ChemotherapyNeoplasm, ResidualNeoplasm MetastasisEpirubicinHematologic DiseasesCamptothecin